Author:
Fiane Ingeborg,Rødland Ernst Kristian,Leegaard Truls M.
Publisher
Springer International Publishing
Reference76 articles.
1. World Health Organisation (WHO). https://www.who.int/drugresistance/activities/wha66_side_event/en/.
2. Vignier N, Bouchaud O. Travel, migration and emerging infectious diseases. eJIFCC. 2018;29:175–9.
3. Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection. 1983;11:315–7.
4. Woerther PL, Andremont A, Kantele A. Travel-acquired ESBL-producing Enterobacteriaceae: impact of colonization at individual and community level. J Travel Med. 2017;24(Suppl 1):S29–34.
5. Pitout JD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother. 2005;56:52–9.